BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15304214)

  • 1. v-Abl signaling disrupts SOCS-1 function in transformed pre-B cells.
    Limnander A; Danial NN; Rothman PB
    Mol Cell; 2004 Aug; 15(3):329-41. PubMed ID: 15304214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor activity of SOCS-1.
    Rottapel R; Ilangumaran S; Neale C; La Rose J; Ho JM; Nguyen MH; Barber D; Dubreuil P; de Sepulveda P
    Oncogene; 2002 Jun; 21(28):4351-62. PubMed ID: 12080466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK-STAT signaling activated by Abl oncogenes.
    Danial NN; Rothman P
    Oncogene; 2000 May; 19(21):2523-31. PubMed ID: 10851051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.
    Qiu X; Guo G; Chen K; Kashiwada M; Druker BJ; Rothman PB; Chen JL
    Neoplasia; 2012 Jun; 14(6):547-58. PubMed ID: 22787435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene.
    Chen JL; Limnander A; Rothman PB
    Blood; 2008 Feb; 111(3):1677-85. PubMed ID: 18042805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abl oncogene bypasses normal regulation of Jak/STAT activation.
    Limnander A; Rothman PB
    Cell Cycle; 2004 Dec; 3(12):1486-8. PubMed ID: 15611644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.
    Zhang JG; Farley A; Nicholson SE; Willson TA; Zugaro LM; Simpson RJ; Moritz RL; Cary D; Richardson R; Hausmann G; Kile BT; Kent SB; Alexander WS; Metcalf D; Hilton DJ; Nicola NA; Baca M
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2071-6. PubMed ID: 10051596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box.
    Hanada T; Yoshida T; Kinjyo I; Minoguchi S; Yasukawa H; Kato S; Mimata H; Nomura Y; Seki Y; Kubo M; Yoshimura A
    J Biol Chem; 2001 Nov; 276(44):40746-54. PubMed ID: 11522790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).
    Giordanetto F; Kroemer RT
    Protein Eng; 2003 Feb; 16(2):115-24. PubMed ID: 12676980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation.
    Frantsve J; Schwaller J; Sternberg DW; Kutok J; Gilliland DG
    Mol Cell Biol; 2001 May; 21(10):3547-57. PubMed ID: 11313480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppressors of cytokine signalling (SOCS).
    Kile BT; Alexander WS
    Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional involvement of Akt signaling downstream of Jak1 in v-Abl-induced activation of hematopoietic cells.
    Oki S; Limnander A; Danial NN; Rothman PB
    Blood; 2002 Aug; 100(3):966-73. PubMed ID: 12130510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jak-STAT signaling induced by the v-abl oncogene.
    Danial NN; Pernis A; Rothman PB
    Science; 1995 Sep; 269(5232):1875-7. PubMed ID: 7569929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families.
    Kamura T; Sato S; Haque D; Liu L; Kaelin WG; Conaway RC; Conaway JW
    Genes Dev; 1998 Dec; 12(24):3872-81. PubMed ID: 9869640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
    To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
    Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS-1 suppresses TNF-alpha-induced apoptosis through the regulation of Jak activation.
    Kimura A; Naka T; Nagata S; Kawase I; Kishimoto T
    Int Immunol; 2004 Jul; 16(7):991-9. PubMed ID: 15173123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation.
    Danial NN; Losman JA; Lu T; Yip N; Krishnan K; Krolewski J; Goff SP; Wang JY; Rothman PB
    Mol Cell Biol; 1998 Nov; 18(11):6795-804. PubMed ID: 9774693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Janus kinase 2 by cisplatin in cancer cells.
    Song H; Sondak VK; Barber DL; Reid TJ; Lin J
    Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.